Inflamed vasculature and inflamed tissues

Inflamed vasculature and inflamed tissues represent a pathological state characterized by the activation of the endothelial lining and the infiltration of immune cells into surrounding areas. This environment is defined by the upregulation of cell adhesion molecules such as Vascular Cell Adhesion Molecule-1 (VCAM-1), Intercellular Adhesion Molecule-1 (ICAM-1), and E-selectin, which facilitate the docking and extravasation of leukocytes (Source: PubMed, PMID: 15123770). In addition to structural changes like increased vascular permeability and vasodilation, these sites exhibit high concentrations of pro-inflammatory cytokines including TNF-alpha, IL-1, and IL-6 (Source: StatPearls, Inflammation). While not a single molecular target, this physiological state serves as a critical focal point for drug delivery systems, such as ligand-directed nanoparticles, designed to release cargo specifically at sites of injury or infection (Source: Nature Reviews Drug Discovery, Targeting inflammation). Therapeutic intervention in these areas aims to resolve chronic inflammation, prevent tissue damage, and restore vascular homeostasis in conditions ranging from atherosclerosis to rheumatoid arthritis. Drugs targeting this environment often act by neutralizing specific cytokines or blocking the interaction between leukocytes and the endothelium (Source: NIH, Vascular Endothelium in Inflammation).

Other names

Inflamed endotheliumInflammatory microenvironmentVascular inflammationSite of inflammation

Therapeutic strategies involve the inhibition of pro-inflammatory cytokines, blockade of leukocyte adhesion molecules, or the use of targeted delivery systems (e.g., nanoparticles) that recognize markers specifically expressed on inflamed endothelial cells.